wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40112906-9489559F-380D-484D-B462-E9C4B769CA85
Q40112906-9489559F-380D-484D-B462-E9C4B769CA85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40112906-9489559F-380D-484D-B462-E9C4B769CA85
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
P2860
Q40112906-9489559F-380D-484D-B462-E9C4B769CA85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40112906-9489559F-380D-484D-B462-E9C4B769CA85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb70b8ba1c0c40b77f36f6abdb059972ccc62458
P2860
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).